Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 1.01, 2.01, 2.02, 7.01, 9.01 · 8-K

Ascent Industries Co.

ACNTNASDAQEQUITYCurrent

Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Results of Operations and Financial Condition · Regulation FD Disclosure

Item 1.01. Entry into a Material Definitive Agreement. On May 4, 2026, Ascent Industries Co. (the “Company”) entered into a definitive agreement (the "Purchase Agreement”) with Midwest Graphics Sales Inc., an Illinois corporation and affiliated entity Sigma Coatings, Inc., an Illinois corporation, collectively (“Seller"), pursuant to which the Company purchased substantially all of the assets and…

Filed May 6, 2026Accepted May 6, 2026, 4:18 PM EDTCIK 95953Accession 0000095953-26-000074
Share

Company context

Ascent Industries Co. (Nasdaq: ACNT) is a specialty chemicals platform delivering differentiated, performance-driven chemical solutions. For more information about Ascent, please visit its website at www.ascentco.com.

Current securities

Historical securities (1)

Recent company filings

  1. Regulation FD DisclosureAug 26, 2026
  2. 10-Q filingAug 4, 2026
  3. Results of Operations and Financial ConditionAug 4, 2026
  4. SCHEDULE 13G/A filingJul 27, 2026
  5. Entry into a Material Definitive AgreementJul 21, 2026

Disclosure sections

Items 1.01, 2.01, 2.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive Agreement. On May 4, 2026, Ascent Industries Co. (the “Company”) entered into a definitive agreement (the "Purchase Agreement”) with Midwest Graphics Sales Inc., an Illinois corporation and affiliated entity Sigma Coatings, Inc., an Illinois corporation, collectively (“Seller"), pursuant to which the Company purchased substantially all of the assets and certain specified liabilities of Seller for $14,000,000, subject to certain customary adjustments for working capital, transaction expenses, and cash, on the terms and subject to the conditions set forth in the Purchase Agreement (the “Transaction”). The Transaction closed simultaneously with the execution of the Purchase Agreement. The Purchase Agreement contains customary representations, warranties and covenants from the parties, including certain indemnification and non-solicitation provisions applicable to Seller and its affiliates. In addition, a portion of the purchase price will be placed into a third-party escrow account to satisfy certain purchase price adjustments and indemnification obligations (if any) of Seller for a period of 18 months post closing. In connection with the Purchase Agreement, the Company received a letter of consent from BMO Bank N.A. ("BMO"), as lender under the Sixth Amendment to Credit Agreement and Omnibus Amendment to Loan Documents dated December 10, 2025 by and between the Company and BMO, consenting to the acquisition of Seller. The foregoing description does not purport to be complete and is qualified in its entirety by reference to (a) the other items of this Current Report on Form 8-K and (b) the Purchase Agreement and Letter of Consent, which are filed herewith as Exhibits 2.1 and 10.1, respectively, and is incorporated by reference herein. A copy of the Purchase Agreement has been included to provide investors with information regarding its terms. It is not intended to provide any other factual information about the parties. In particular, the Purchase Agreement contains representations, warranties and covenants that were made as of specific dates and only for the benefit of the parties to the Purchase Agreement and are qualified by information included in confidential disclosure schedules. Moreover, certain representations, warranties and covenants in the Purchase Agreement were made for the purpose of allocating risk between the parties rather than establishing matters as facts. Accordingly, the representations, warranties and covenants in the Purchase Agreement should not be relied upon as characterizations of the actual state of facts about the parties to the agreement.
Item 2.01Item 2.01 - Completion of Acquisition
Item 2.01. Completion of Acquisition or Disposition of Assets. The information set forth under Item 1.01 above is hereby incorporated into this Item 2.01 by reference.
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition On May 6, 2026, the Company issued a press release announcing financial information for its first quarter ended March 31, 2026. The press release is attached as Exhibit 99.1 to this Form 8-K and is furnished to, but not filed with, the Commission.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On May 6, 2026, the Company issued a press release and acquisition supplement announcing that it had entered into the Purchase Agreement. A copy of the press release and acquisition supplement are attached hereto as Exhibits 99.2 and 99.3, respectively. The information contained in Exhibits 99.2 and 99.3 is furnished under this Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) acnt-20260331ex991.htm

EX-99.1 4 acnt-20260331ex991.htm EX-99.1 Document Exhibit 99.1 Schaumburg, Illinois, May 6, 2026 - Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), a specialty chemicals platform delivering differentiated, performance-driven chemical solutions, is reporting its results for the first quarter ended March 31, 2026. First Quarter 2026 Summary1 (in millions, except per share and margin) Q1 2026 Q1 2025 Change ───────────────────────────────────────────────────────────────────────────────────── Net Sales $19.4 $17.8 9.0% Gross Profit $2.8 $3.1 (8.3)% Gross Profit Margin 14.5% 17.2% -272bps Net Loss $(2.0) $(2.2) (9.0)% Diluted Loss per Share $(0.21) $(0.22) (4.5)% Adjusted EBITDA $(1.0) $(0.5) -$0.5M Adjusted EBITDA Margin (5.0)% (2.6)% -235bps ______________ 1On June 30, 2025, the Company closed on a transaction to sell su…

Open exhibit ↗